STOCK TITAN

Capstone Holding Corp. Form 4 Filings

CAPS NASDAQ

Every Form 4 that Capstone Holding Corp. (CAPS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CAPS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CAPS filings page.

Rhea-AI Summary

FELDMAN FREDRIC J reported acquisition or exercise transactions in this Form 4 filing.

Capstone Holding Corp. reported that director Fredric J. Feldman received two grants of unvested restricted common stock. He was awarded 95,000 shares on March 30, 2026 and 105,124 shares on August 7, 2026 under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. The awards were granted for no consideration, may not be sold, transferred or pledged, and will vest in full only upon his Separation Date as defined in his Master Restricted Stock Agreement.

Rhea-AI Summary

Grotke Kevin Allan reported acquisition or exercise transactions in this Form 4 filing.

Capstone Holding Corp. reported that Kevin Allan Grotke, President & CEO of TotalStone, received a grant of 515,495 shares of unvested restricted common stock on August 7, 2026, for no consideration, under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. These restricted stock awards may not be sold, transferred or pledged and will vest in full on August 7, 2029, subject to his continued service. Following this grant, his directly held common stock position is 1,041,597 shares.

Rhea-AI Summary

HOLLIMAN JOHN M III reported acquisition or exercise transactions in this Form 4 filing.

Capstone Holding Corp. director John M. Holliman III reported two equity compensation awards of unvested restricted Common Stock. He received 95,000 shares on March 30, 2026 and 305,248 shares on August 7, 2026, granted for no consideration under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. These restricted shares may not be sold, transferred, or pledged and will vest in full only upon his Separation Date, as defined in his Master Restricted Stock Agreement.

Rhea-AI Summary

HOWSE ELWOOD D reported acquisition or exercise transactions in this Form 4 filing.

Capstone Holding Corp. director Elwood D. Howse reported two equity compensation awards of common stock. He received 95,000 shares on March 30, 2026 and 105,124 shares on August 7, 2026 as unvested restricted stock, granted for no consideration under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. The awards may not be sold, transferred, or pledged and will vest in full only upon his Separation Date, as defined in his Master Restricted Stock Agreement.

Rhea-AI Summary

Lipman Matthew E. reported acquisition or exercise transactions in this Form 4 filing.

Capstone Holding Corp. reported that Chief Executive Officer and director Matthew E. Lipman, also a more-than-10% owner, received a grant of 1,094,648 shares of unvested restricted common stock on August 7, 2026 for no consideration under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. These restricted stock awards may not be sold, transferred, or pledged and will vest in full on August 7, 2029, subject to his continued service. Following this award, he directly holds 1,492,648 shares of common stock.

Rhea-AI Summary

SCHULTZ EDWARD CHRISTOPHER reported acquisition or exercise transactions in this Form 4 filing.

Capstone Holding Corp. reported that its Chief Financial Officer, Edward Christopher Schultz, received a grant of 310,310 shares of unvested restricted common stock on August 7, 2026 under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended. These shares were granted for no consideration and may not be sold, transferred or pledged until they vest. The restricted stock is scheduled to vest in full on August 7, 2029, subject to his continued service. Following this award, Schultz directly holds 500,310 shares of the company’s common stock.

Rhea-AI Summary

Capstone Holding Corp. director Gordon Lewis Strout Jr reported multiple equity acquisitions in Capstone Holding Corp. common stock. On March 7, 2025, all Preferred Interests in TotalStone, LLC previously owned by him were exchanged under a Master Exchange Agreement for 822,128 shares of common stock held indirectly through Gordon Rocks, Inc. On March 7, 2025, he also purchased 41,500 common shares at $4.00 per share. In addition, he received unvested restricted stock awards of 142,500 shares on March 30, 2026 and 357,810 shares on August 7, 2026 for no consideration under the Capstone Holding Corp. 2025 Stock Incentive Plan; these restricted shares may not be sold, transferred, or pledged and will vest in full only upon his Separation Date as defined in his Master Restricted Stock Agreement.

Rhea-AI Summary

Capstone Holding Corp. reported that director Michael Toporek acquired 1,094,647 shares of Common Stock on August 7, 2026 via a grant/award, not a market purchase. These shares are unvested restricted stock, granted for no consideration under the Capstone Holding Corp. 2025 Stock Incentive Plan, as amended.

The restricted stock may not be sold, transferred, or pledged and will vest in full only upon the Reporting Person's Separation Date, as defined in the Master Restricted Stock Agreement. Following this grant, Toporek directly holds 1,492,647 shares of Capstone Holding Corp. common stock.

Rhea-AI Summary

TOPOREK MICHAEL reported acquisition or exercise transactions in this Form 4 filing.

Capstone Holding Corp. director Michael Toporek reported an amended grant of 356,250 shares of common stock as restricted stock awards on March 30, 2026, issued for no consideration. These shares vest only upon specified Board-related events, bringing his reported direct holdings to 391,678 shares, excluding 121,774 shares controlled through BP Peptides, LLC.

Rhea-AI Summary

Capstone Holding Corp. director Michael Toporek purchased 41,750 shares of Common Stock on March 7, 2025 at $4.00 per share in a purchase in open market or private transaction. After this transaction, he directly holds 41,750 Capstone Holding Corp. Common Stock shares.

Rhea-AI Summary

Capstone Holding Corp. director and Chief Executive Officer Matthew E. Lipman reported purchasing 41,750 shares of Common Stock at $4.00 per share on March 7, 2025, increasing his direct holdings to 2,570,412 shares. The transaction is not designated under a Rule 10b5-1 trading plan.

Rhea-AI Summary

Lipman Matthew E. reported acquisition or exercise transactions in this Form 4 filing.

Capstone Holding Corp. amended a prior insider report to clarify that Chief Executive Officer Matthew E. Lipman received a grant of 356,250 shares of common stock as restricted stock awards on March 30, 2026, vesting in full on March 30, 2029, for no consideration.

After this grant, he directly holds 2,920,340 shares of common stock. This figure excludes an additional 121,774 shares he controls through BP Peptides, LLC.

Rhea-AI Summary

SCHULTZ EDWARD CHRISTOPHER reported acquisition or exercise transactions in this Form 4 filing.

An insider disclosure for Capstone Holding Corp. states that Chief Financial Officer Edward Christopher Schultz received a grant of 190,000 shares of common stock on March 30, 2026 as restricted stock awards, for no consideration. These shares vest in full on March 30, 2029, subject to his continued service. The Form 4/A amendment corrects an earlier description, clarifying that the grant consists of common shares rather than restricted stock units.

Rhea-AI Summary

SCHULTZ EDWARD CHRISTOPHER reported acquisition or exercise transactions in this Form 4 filing.

Capstone Holding Corp. reported that Chief Financial Officer Edward Christopher Schultz received a grant of restricted stock units covering 190,000 shares of common stock. The award was granted on March 30, 2026 at a reference value of $0.649 per share and represents equity-based compensation rather than an open-market purchase.

The RSUs will vest in full on March 30, 2029, the third anniversary of the grant date, provided Schultz continues to serve with the company through that vesting date. Following this grant, he is reported as directly holding 190,000 shares underlying this restricted stock award.

Rhea-AI Summary

Lipman Matthew E. reported acquisition or exercise transactions in this Form 4 filing.

Capstone Holding Corp. reported that Chief Executive Officer Matthew E. Lipman received a grant of 356,250 Restricted Stock Awards on March 30, 2026. Each award relates to one share of common stock at a reference value of $0.649 per share.

The award is compensation, not an open-market purchase or sale, and increases his directly held restricted stock to 356,250 shares from this grant. According to the terms, these RSUs vest in full on March 30, 2029, the third anniversary of the grant date, if he continues serving the company through that date.

Rhea-AI Summary

TOPOREK MICHAEL reported acquisition or exercise transactions in this Form 4 filing.

Capstone Holding Corp. director Michael Toporek received a grant of 356,250 restricted stock units tied to common stock. The award was valued at $0.649 per underlying share. According to the terms, the RSUs vest in full on March 30, 2029, subject to his continued service through that date.